The Effect of Art-based Mandala Intervention (mandala)

March 23, 2026 updated by: Berna Dincer, Istanbul Medeniyet University

The Effect of Art-based Mandala Intervention on Death Anxiety and Anger Levels in Elderly Adults Living in Nursing Homes: A Randomized Controlled Study

Objective This study aimed to investigate the effect of art-based mandala intervention on anger and death anxiety in older adults residing in a nursing home.

Methods A randomized controlled experimental study with 80 participants (experimental group n = 40; control group n = 40) was conducted. The experimental group participated in mandala coloring three times a week for 12 weeks. Data were collected using a descriptive form, a death anxiety scale, and the State-Trait Anger Expression Inventory.

Study Overview

Detailed Description

Objective This study aimed to investigate the effect of art-based mandala intervention on anger and death anxiety in older adults residing in a nursing home.

Methods A randomized controlled experimental study with 80 participants (experimental group n = 40; control group n = 40) was conducted. The experimental group participated in mandala coloring three times a week for 12 weeks. Data were collected using a descriptive form, a death anxiety scale, and the State-Trait Anger Expression Inventory.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kartal
      • Istanbul, Kartal, Turkey (Türkiye), 34862
        • Istanbul Medeniyet University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • residing in the nursing home, being 65 years of age or older, scoring 24 or more points on the Mini-Mental State Examination, having no psychiatric diagnoses, not currently participating in courses related to coping with anxiety and stress, and voluntarily agreeing to participate in the study.

Exclusion Criteria:

  • out of the inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mandala
Mnadala coloring
Other: Control
do nothing
do nothing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Death Anxiety Scale
Time Frame: Baseline and 12 weeks follow-up
Death Anxiety Scale: The validity and reliability study of the Turkish version of the "Death Anxiety Scale". The scale 15-item true/false scale measures anxiety and fear related to one's own death and mortality risk. Each "yes" response to the first nine items and each "no" response to the remaining six items receives a score of "1." The total score indicates the level of death anxiety. The maximum possible score is 15, with scores interpreted as follows: 0-4 (mild), 5-9 (moderate), 10-14 (severe), and 15 (panic).
Baseline and 12 weeks follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 12, 2024

Primary Completion (Actual)

April 24, 2025

Study Completion (Actual)

June 23, 2025

Study Registration Dates

First Submitted

March 11, 2026

First Submitted That Met QC Criteria

March 23, 2026

First Posted (Actual)

March 27, 2026

Study Record Updates

Last Update Posted (Actual)

March 27, 2026

Last Update Submitted That Met QC Criteria

March 23, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ıstanbulımu IMU-2026-BD

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe